CMI_DM Blogger

    Immune checkpoint inhibitors are a type of immunotherapy drug. Although traditional chemotherapeutic drugs are still the first-line treatment option for most cancer types, targeted immune therapies are becoming standard treatments for advanced-stage cancers. These drugs target cell surface checkpoint proteins to stimulate the immune system's recognition and destruction of cancer cells.   The global immune checkpoint inhibitors market is growing due to an increase in cancer prevalence across geographies and increased awareness of immune checkpoint inhibitors. Furthermore, technological advancements in cancer screening procedures, increased healthcare expenditures, an increase in government initiatives to alleviate cancer, and an increase in public awareness is expected to drive market growth.  The human body's immune system is dependent on multiple checkpoints or immunological breaks that prevent the over-activation of healthy cells or the immune system. Tumor or cancerous